Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Surgery for Gynecologic Malignancies

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL

Istanbul Medical Journal Pub Date : 2023-05-31 DOI:10.4274/imj.galenos.2023.86143

H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran

引用次数: 0

Abstract

933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.

查看原文本刊更多论文

妇科恶性肿瘤手术患者静脉血栓栓塞的发生率及危险因素

933；p=0.039；或：0.002；95%置信区间：0.001-0.025；p=0.001；或：0.217；95%置信区间：0.082-0.577；p=0.002；或：0.033；95%置信区间：0.003-0.379；p分别为0.006）。结论：我们建议每一位接受妇科肿瘤手术的患者都应该进行术前药物和术后扩展的双重预防，以实现该组VTE的最低发病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊